UCB is a multinational biopharmaceutical company. It specialises in neurology, immunology and rare diseases.
Sectors
- News & Analysis
UCB
Nov 17, 2023 • GCV reporters
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.EventsGCV Institute: CVC Investment ProgramsJan 28 -
Jan 29, 2025
OnlineEventsGCV Institute: CVC Investment ProgramsMar 17 -
Mar 18, 2025
Palo Alto, CA (USA)EventsGCVI Summit 2025Mar 18 -
Mar 20, 2025
Monterey, CA (USA)EventsGCV Institute: Landing the Value of Corporate VenturingMay 1 -
May 6, 2025
OnlineEventsGCV Symposium 2025Jun 17 -
Jun 19, 2025
London (UK)Top News
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2024 Mawsonia Ltd. All rights reserved.test regLogin